These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 15053447
1. The Nijmegen inception cohort of early rheumatoid arthritis. Welsing PM, van Riel PL. J Rheumatol Suppl; 2004 Mar; 69():14-21. PubMed ID: 15053447 [Abstract] [Full Text] [Related]
2. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Welsing PM, Fransen J, van Riel PL. Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762 [Abstract] [Full Text] [Related]
3. Performance of a rheumatoid arthritis records-based index of severity. Ting G, Schneeweiss S, Katz JN, Weinblatt ME, Cabral D, Scranton RE, Solomon DH. J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860 [Abstract] [Full Text] [Related]
4. Established rheumatoid arthritis: clinical assessments. van Riel PL, Fransen J. Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):807-25. PubMed ID: 17870029 [Abstract] [Full Text] [Related]
5. The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden. Kristensen LE, Saxne T, Geborek P. Arthritis Rheum; 2006 Feb; 54(2):600-6. PubMed ID: 16447237 [Abstract] [Full Text] [Related]
6. Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study. Kroot EJ, van Gestel AM, Swinkels HL, Albers MM, van de Putte LB, van Riel PL. J Rheumatol; 2001 Jul; 28(7):1511-7. PubMed ID: 11469455 [Abstract] [Full Text] [Related]
7. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL, Watson KD, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register. Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046 [Abstract] [Full Text] [Related]
8. Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic? de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Rheumatology (Oxford); 2011 Jan; 50(1):93-100. PubMed ID: 20639266 [Abstract] [Full Text] [Related]
9. Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort. Kahn KL, Maclean CH, Wong AL, Rubenstein LZ, Liu H, Fitzpatrick DM, Harker JO, Chen WP, Traina SB, Mittman BS, Hahn BH, Paulus HE. Arthritis Rheum; 2007 Jun 15; 57(5):707-15. PubMed ID: 17530663 [Abstract] [Full Text] [Related]
10. Functional outcome and subset identification in RA patients from meridional Europe: analysis of a Spanish cohort. Calvo-Alén J, Corrales A, Sánchez-Andrada S, Fernández-Echevarría MA, Peña JL, Rodriguez-Valverde V. Clin Rheumatol; 2003 May 15; 22(2):77-83. PubMed ID: 12740668 [Abstract] [Full Text] [Related]
11. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability. Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, Singh G, Yamanaka H. Ann Rheum Dis; 2008 Aug 15; 67(8):1153-8. PubMed ID: 17971459 [Abstract] [Full Text] [Related]
12. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Cañete JD, Suárez B, Hernández MV, Sanmartí R, Rego I, Celis R, Moll C, Pinto JA, Blanco FJ, Lozano F. Ann Rheum Dis; 2009 Oct 15; 68(10):1547-52. PubMed ID: 18930989 [Abstract] [Full Text] [Related]
13. Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health. Kievit W, Welsing PM, Adang EM, Eijsbouts AM, Krabbe PF, van Riel PL. Arthritis Rheum; 2006 Oct 15; 55(5):745-50. PubMed ID: 17013821 [Abstract] [Full Text] [Related]
14. Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice. Kahn KL, MacLean CH, Liu H, Rubenstein LZ, Wong AL, Harker JO, Chen WP, Fitzpatrick DM, Bulpitt KJ, Traina SB, Mittman BS, Hahn BH, Paulus HE. Arthritis Rheum; 2006 Dec 15; 55(6):884-91. PubMed ID: 17139665 [Abstract] [Full Text] [Related]
15. Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record-based disease activity calculator. Collier DS, Grant RW, Estey G, Surrao D, Chueh HC, Kay J. Arthritis Rheum; 2009 Apr 15; 61(4):495-500. PubMed ID: 19333984 [Abstract] [Full Text] [Related]
18. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes. Wolfe F, Michaud K, Pincus T, Furst D, Keystone E. Arthritis Rheum; 2005 Dec 15; 52(12):3873-9. PubMed ID: 16320335 [Abstract] [Full Text] [Related]
19. Therapeutic strategies in rheumatoid arthritis over a 40-year period. Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE. J Rheumatol; 2004 Dec 15; 31(12):2366-73. PubMed ID: 15570636 [Abstract] [Full Text] [Related]
20. Outcome in rheumatoid arthritis. A 1985 inception cohort study. Suarez-Almazor ME, Soskolne CL, Saunders LD, Russell AS. J Rheumatol; 1994 Aug 15; 21(8):1438-46. PubMed ID: 7983643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]